Rhythm Pharmaceuticals (RYTM) Invested Capital (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Invested Capital of $10.1 million for Q1 2026, up 537.11% year-over-year from $1.6 million in Q1 2025, and up 38.84% quarter-over-quarter from $7.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Invested Capital (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Invested Capital for 4 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 537.11% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $26.8 million (up 754.68% YoY), while the FY2025 annual figure was $7.3 million, up 373.46% from the prior year.
- Invested Capital improved to $10.1 million in Q1 2026 per RYTM's latest filing, from $7.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $10.1 million in Q1 2026 and bottomed at $1.5 million in Q4 2024.
- Historically, Invested Capital has averaged $5.0 million across 3 years, with a median of $4.7 million in 2025.
- Annual changes were most pronounced in 2025 — Invested Capital soared 373.46% — and 2026, when it soared 537.11%.
- Rhythm Pharmaceuticals' Invested Capital stood at $1.5 million in 2024, then jumped by 373.46% to $7.3 million in 2025, then soared by 38.84% to $10.1 million in 2026.
- Business Quant data shows RYTM's Invested Capital at $10.1 million in Q1 2026, $7.3 million in Q4 2025, and $5.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 12.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.70 Mn |
| Mar 31, 2026 | 10.13 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Dec 31, 2016 | 105,000.00 |